Medically reviewed by Drugs.com. Last updated on Sep 17, 2020.
(ne TAR soo dil)
Excipient information presented when available (limited, particularly for generics); consult specific product labeling.
Rhopressa: 0.02% (2.5 mL) [contains benzalkonium chloride]
Brand Names: U.S.
- Rho Kinase Inhibitor
Although the exact mechanism of action of netarsudil, a rho kinase inhibitor, is unknown, it may reduce IOP by increasing the outflow of aqueous humor through the trabecular meshwork route.
Metabolized by esterases in the eye to active metabolite AR-13503.
Use: Labeled Indications
Elevated intraocular pressure (IOP): Reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension
There are no contraindications listed in the manufacturer's labeling
Elevated intraocular pressure: Ophthalmic: Instill 1 drop into affected eye(s) once daily in the evening (maximum: 1 drop into affected eye(s) once daily).
Refer to adult dosing.
Ophthalmic: For ophthalmic use only. May be used with other eye drops to lower intraocular pressure. If using more than 1 ophthalmic product, wait at least 5 minutes in between application of each medication. Remove contact lenses prior to administration and wait at least 15 minutes (after administration) before reinserting. Avoid touching the dropper tip with fingers, eyes, eyelids, or surrounding areas to minimize contamination of the dropper tip.
Store at 2°C to 8°C (36°F to 46°F) until opened. After opening, may store refrigerated at 2°C to 8°C (36°F to 46°F) until the manufacturer's expiration date or at ≤25°C (≤77°F) for ≤6 weeks. During shipment, may maintain at temperatures ≤40°C (≤104°F) for ≤14 days.
There are no known significant interactions.
The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.
Local: Application site pain (20%)
Ophthalmic: Conjunctival hyperemia (53%), conjunctival hemorrhage (20%), corneal deposits (20%; verticillata)
1% to 10%:
Dermatologic: Erythema of eyelid (5% to 10%)
Local: Application site erythema (5% to 10%)
Ophthalmic: Blurred vision (5% to 10%), corneal staining (5% to 10%), decreased visual acuity (5% to 10%), increased lacrimation (5% to 10%)
Concerns related to adverse effects:
• Bacterial keratitis: Inadvertent contamination of multiple-dose ophthalmic solutions has caused bacterial keratitis.
• Contact lens wearers: Contains benzalkonium chloride, which may be absorbed by soft contact lenses. Remove contact lens prior to instillation; may reinsert 15 minutes following administration.
Adverse events were not observed in animal reproduction studies following clinically relevant systemic exposure. Systemic absorption is minimal following ophthalmic application. If ophthalmic agents are needed during pregnancy, the minimum effective dose should be used in combination with punctal occlusion to decrease potential exposure to the fetus (Samples 1988).
What is this drug used for?
• It is used to treat glaucoma.
• It is used to lower high eye pressure.
All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor or get medical help if any of these side effects or any other side effects bother you or do not go away:
• Blurred vision
• Watery eyes
WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect:
• Vision changes
• Eye pain
• Severe eye irritation
• Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
Note: This is not a comprehensive list of all side effects. Talk to your doctor if you have questions.
Consumer Information Use and Disclaimer: This information should not be used to decide whether or not to take this medicine or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a limited summary of general information about the medicine's uses from the patient education leaflet and is not intended to be comprehensive. This limited summary does NOT include all information available about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not intended to provide medical advice, diagnosis or treatment and does not replace information you receive from the healthcare provider. For a more detailed summary of information about the risks and benefits of using this medicine, please speak with your healthcare provider and review the entire patient education leaflet.
More about netarsudil ophthalmic
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- En Español
- 28 Reviews
- Drug class: ophthalmic glaucoma agents
- Other brands
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.